Epidemiology Intelligence

Portfolio Strategy and Business Development

Size your market accurately with comprehensive epidemiology data

The complete epidemiology market picture

Confidently size your market and understand target patient populations using a single source of epidemiology intelligence, featuring a unique combination of incidence and prevalence literature review, in-depth disease-specific forecasts and U.S. claims-based insights.

Benchmark

Benchmark your forecasts with epidemiology data on the total potential and addressable market.

Validate

Validate your investments and identify growth opportunities using bottom-up forecasting.

Estimate

Confidently estimate drug-treated populations and understand how populations will change over time.

Broad and deep coverage of disease epidemiology

Accurate market sizing to shape your strategy

Benchmark forecasts effectively

Quantify the total potential and addressable market and understand how patient populations change over time. Estimate drug-treated and drug-treatable populations with 20-year epidemiology forecasts spanning 45 countries, plus additional forecasts across 171 countries with our proprietary Extrapolated World Coverage dashboard.

Quick and efficient market sizing

Make preliminary market sizing assessments across thousands of indications, including niche and rare diseases. Leverage a trusted literature review of diseases, procedures, symptoms and other health issues for incidence, prevalence, morbidity, mortality, comorbidity, treated or diagnosed rates and cost.

Identify growth opportunities

Make empowered decisions on a potential asset’s lucrativeness in a particular market based on patient population growth dynamics, and understand disease stratification in a market by attributes like diagnosed and drug-treated status, stage of a disease, severity etc.